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Herein, we describe a protocol for the preparation and analysis of primary
isolated rat hepatocytes in a 3D cell culture format described as spheroids.
The hepatocyte cells spontaneously self-aggregate into spheroids without the
need for synthetic extracellular matrices or hydrogels. Primary rat hepatocytes
(PRHs) are a readily available source of primary differentiated liver cells and
therefore conserve many of the required liver-specific functional markers, and
elicit the natural in vivo phenotype when compared with common hepatic cells
lines. We describe the liquid-overlay technique which provides an ultra-low
attachment surface on which PRHs can be cultured as spheroids. C© 2019 The
Authors.
Basic Protocol 1: Preparation of agarose-coated plates
Basic Protocol 2: Primary rat hepatocyte isolation procedure
Basic Protocol 3: Primary rat hepatocyte spheroid culture
Basic Protocol 4: Immunofluorescent analysis of PRH spheroids
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INTRODUCTION
Drug-induced hepatotoxicity remains one of the leading causes of global acute liver
failure, which can lead to patient hospitalization, discontinuation of essential and
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life-preserving treatments, and the need for liver transplantation. It is also one of the
leading causes of drug attrition during several stages in the drug development process.
This is partially due to our incomplete understanding of drug metabolism and clearance
in human systems that results from the unavailability of relevant and accessible transla-
tional in vitro liver models. Therefore, the development of improved in vitro platforms
to assess liver toxicity after repeat-dose exposure to xenobiotics is crucial to efficiently
bring new compounds safely to market in a cost-effective and timely manner.
Three-dimensional (3D) culture techniques, such as supporting extracellular matrices
(ECM), hydrogels, hanging-drop cultures, and spheroids, have been shown to more
closely recapitulate the in vivo microenvironment, allowing for extended viable culture
periods compared to conventional two-dimensional (2D) cell cultures (Godoy et al.,
2013; Kyffin et al., 2018). The culturing of cells in a spheroid conformation increases
the number of cell-cell and cell-ECM interactions, and these interactions mediate the
behavioral and phenotypic characteristics of the cells, allowing for cultures to mimic
the in vivo situation in a more representative way (Kyffin et al., 2019). There have
been a number of published articles describing methods by which to produce spheroids,
including the much utilized hanging-drop method. A notable paper describing this culture
platform was published by Messner and colleagues, and this method has now been fully
commercialized (i.e., by InSphero) such that ‘ready-made’ plates of spheroids can be
purchased (Messner, Agarkova, Moritz, & Kelm, 2013). A significant hindrance to the
widespread adoption of this commercial model and other similar platforms as early-stage
screening tools, both in research and in industry, is their considerable cost. Consequently,
there has been a requirement for the development and implementation of simpler and
cheaper alternatives.
Although other methods have been used to produce spheroids, such as rocked cultures
and spinner flasks, a caveat of these approaches is the inability to control the resulting
size of the spheroids, leading to limitations in precision when comparing results across
studies. Moreover, the inability to control the size of spheroids leads to a more substantial
problem whereby oxygen and other vital nutrients are unable to diffuse into the central
regions of larger spheroids, and this can result in cellular necrosis due to hypoxia (Anada,
Fukuda, Sai, & Suzuki, 2012). This article describes an efficient method to generate and
culture primary rat hepatocyte (PRH) spheroids using the liquid-overlay technique (LOT).
Alternatives will also be given to allow choice of protocols based on time and financial
availability. We also describe the hepatocyte isolation procedure in detail, as well as the
main immunofluorescence protocol used to characterize the properties of the resultant
PRH spheroids.
This article begins with the standard protocol for the production of agarose-coated, ultra-
low attachment (ULA) plates (Basic Protocol 1), followed by the complete PRH isolation
procedure using livers of male Wistar rats (Basic Protocol 2). We also describe the ba-
sic culture conditions required for the maintenance of the PRH spheroids for extended
periods when implementing the LOT (Basic Protocol 3), and the specific immunoflu-
orescence protocol for the staining and imaging of bile cannalicular-like structures via
P-glycoprotein (P-gp) immunostaining (Basic Protocol 4).
NOTE: All protocols using live animals must first be reviewed and approved by the
local Animal Welfare and Ethical Review Body and must conform to governmental
regulations regarding the care and use of laboratory animals. Additionally, these protocols
are to be carried out in accordance with the principles of the Basel Declaration and
recommendations of the ARRIVE guidelines issued by the NC3Rs. All work must be
authorized by the Home Office under the Animals (Scientific Procedures) Act 1986 and
the EU Directive.Kyffin et al.
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NOTE: The procedures involving cell cultures are to be performed in a Class II biological
safety cabinet, and everything entering the hood must be sprayed with a 70% alcohol
solution. All solutions and equipment coming into contact with PRH cultures post-
isolation must be sterile, and aseptic technique must be implemented accordingly.
NOTE: All culture incubations should be performed in a humidified 37°C, 5% CO2
incubator unless specified otherwise.
BASIC
PROTOCOL 1
PREPARATION OF AGAROSE-COATED PLATES
This protocol describes the necessary procedure for the preparation of agarose-coated
ULA plates required for PRH spheroid culture. The underlying principle for the pro-
duction of spheroids using this methodology is that monodispersed cells are capable of
reforming a 3D configuration via self-reaggregation if adhesion to the substrate in which
they are being cultured is prevented (Kelm et al., 2006). Furthermore, the prevalent the-
ory of self-assembly also suggests that, in the absence of external influences, cells will
self-organize into a spherical conformation (Napolitano, Chai, Dean, & Morgan, 2007).
Materials
Agarose (high gelling temperature; Merck-Sigma A7174)
Williams’ Medium E (basal medium; Merck-Sigma W1878)
Digital scale, calibrated
25-ml pipette (Thermo Fisher Scientific Sterilin 10693961) and pipette controller
250-ml Pyrex glass medium bottle
Autoclave tape
Sterile reservoirs (STARLAB E2310-1010)
8-channel multichannel pipettor
200-µl filter pipette tips (Elkay AER-REF-S96)
96-well flat-bottom sterile cell culture plate (Thermo Fisher Scientific 10212811)
Zip-lock bags
Production of liquid-overlay plates
1. Weigh out 3 g of agarose using a calibrated digital scale.
2. Using a pipette controller and 25-ml pipette, transfer 200 ml of basal Williams’
Medium E into a 250-ml Pyrex medium bottle and add the agarose. Mix the solution
by inverting the bottle. Note that the agarose will not dissolve until it is heated in
the autoclave.
3. Loosely screw the lid onto the Pyrex medium bottle and secure the lid using autoclave
tape. Autoclave this solution.
3 g of agarose and 200 ml of basal medium will make enough agarose to coat approxi-
mately 16 plates.
4. After autoclaving has finished, ensure that the agarose is completely molten by
microwaving prior to coating culture plates.
Note that solution will be extremely hot, and care must be taken in handling.
5. In the sterile tissue culture hood, pour the autoclaved solution into sterile reservoirs
and pipette 100 µl agarose solution (ensure that there are no air bubbles) into the
inner 60 wells of a 96-well flat bottom sterile cell culture plate using an 8-channel
pipettor.
Note that the outer wells will not be used to culture spheroids due to a boundary evapo-
ration effect. See Figure 1 for culture plate layout. Kyffin et al.
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Figure 1 Spheroid culture plate layout. Red crosses indicate the wells that are not used for
spheroid culture. All other wells are used to seed PRH for spheroid generation.
6. Allow agarose to set in the tissue culture hood for at least 30 min with the lids left
off the 96-well plates.
7. Replace the lids of the 96-well plates and seal in plastic ziplock bags. Date the bags
and ensure that the plates are stored inverted at 4°C.
Plates can be stored for up to 4 weeks.
8. Leave culture plates at 4°C for at least 2 weeks to allow for appropriate hydration
prior to cell seeding.
Using plates within this 2-week period can result in malformation of spheroids.
If cost is not a limiting factor, premade ULA plates (Corning 96-well Ultra Low Attach-
ment; Corning Life Sciences; ThermoFisher Scientific 10023683) can be purchased and
substituted for the agarose-coated plates for PRH spheroid generation.
BASIC
PROTOCOL 2
PRIMARY RAT HEPATOCYTE ISOLATION PROCEDURE
This procedure describes the principal methodology for the isolation of hepatocytes from
the whole liver of a young adult male Wistar rat, weighing between 175 and 200 g,
and the subsequent purification steps for these parenchymal cells. This protocol is a
modified version of the two-step collagenase perfusion technique described originally
by Seglen (1976). The procedure need not be conducted in an aseptic environment, as
the culture of the PRHs is considered relatively “short-term.” In order to achieve the
highest number of healthy and viable hepatocytes during the isolation, well-prepared,
planned dissection and isolation are essential. This is dependent upon the use of fresh
materials and solutions, usually prepared on the morning of the isolation procedure or
the night before (e.g., for a Monday isolation, buffers may be prepared on the preceding
Friday and stored at 4°C). Additionally, minimization of the time between anesthesia
and the purification of isolated hepatocytes is vital. A single liver from a rat typically
provides approximately 300 million hepatocytes (Cho, Berthiaume, Tilles, & Yarmush,
2008). A single rat liver isolation would, therefore, provide hepatocytes for numerous
rounds of spheroid production and hundreds of potential cultures. As such, we suggest the
implementation of tissue-sharing schemes as endorsed by the NC3Rs; alternatively, cell
suspensions may be cryopreserved and used for other studies at a later date (Stevenson,
Morgan, McLellan, & Helen Grant, 2007).
Kyffin et al.
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Materials
Wash buffer for hepatocyte isolation (see recipe), prewarmed to 47°C for a
minimum of 30 min
Digestion buffer (see recipe), prewarmed to 47°C for a minimum of 30 min
Centrifugation buffer (see recipe), prewarmed to 47°C for a minimum of 30 min
Complete Williams’ Medium E (see recipe)
Collagenase A (from Clostridium histolyticum; Roche 11088793001)
DNase I (Merck-Sigma D5025)
Trypsin inhibitor (type 1-S from soybean; Merck-Sigma 10109886001)
70% ethanol
Male Wistar rat (175-200 g)
Sagatal (anesthetic; Rhone Merieux Ltd., Harlow, U.K.)
0.4% (w/v) trypan blue (Thermo Fisher Scientific 15250061)
5-ml bijou bottles
50-ml conical tubes (e.g., Corning Falcon)
Blue roll
Dissection tray
Tape
Cotton tie
Cotton swabs
Petri dish
Dissection tools including:
Surgeon’s scissors
Cross-action forceps
Iris scissors
Blunt forceps
125-µm nylon gauze
250-ml glass beaker
25-G needle (VWR 613-0902)
1-ml syringe (Appleton Woods BD572)
18-G inflow cannula (portal vein)
Ziplock bags
Perfusion apparatus including:
Peristaltic pump
Tubing
Glass vial for bubble trap
Heated water bath at 37°C
0.5-ml microcentrifuge tubes
Hemacytometer and coverslip
Inverted microscope
Preparation for hepatocyte isolation and culture
Prepare wash buffer (for hepatocyte isolation), digestion buffer, and centrifugation buffer
on the day before the isolation procedure.
Pre-surgery setup (morning of rat hepatocyte isolation)
1. Pre-warm the wash buffer for hepatocyte isolation, digestion buffer, and centrifuga-
tion buffer at 47°C for a minimum of 30 min.
2. Pre-warm the culture medium (complete Williams’ Medium E) at 37°C.
3. Pre-cool the centrifuge at 4°C.
4. Weigh out into three separate 5-ml bijou bottles: Kyffin et al.
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50 mg collagenase
6.8 mg trypsin inhibitor
20 mg DNase I.
Store bijous on ice along with two 50-ml conical tubes.
5. Set up culture hood for cell washing—spray hood down with 70% ethanol and put
in necessary equipment.
6. Set up surgical tray for isolation, cotton swabs, blue roll, tape, cotton, petri dish, and
dissection tools.
7. Cut nylon gauze squares ready for isolation (approximately 12 × 12 cm).
8. Clean 250-ml beaker with distilled water, spray with 70% ethanol, and rinse again
with distilled water.
9. Place 25-G needle, 1-ml syringe, and 18-G cannula next to the dissection tray.
10. Prepare an additional ziplock bag.
Set up for surgery
11. Prime the perfusion apparatus with the pre-warmed wash buffer for hepatocyte
isolation (50 ml; remove as much air as possible). Ensure that the bubble trap
contains only buffer and no air bubbles. Ensure that the wash buffer is eluting from
the syringe, and begin the procedure.
12. Secure the bubble trap in the clamp and arrange tubing through the pump teeth
so that tubing is able to reach the water bath and easily reach the bubble trap and
surgical area.
13. Adjust the perfusion flow rate to approximately 20 ml/min. Transfer the tubing to
wash buffer for hepatocyte isolation.
It is vital to adjust the flow rate here appropriately, as a too-low flow rate can lead to
incomplete perfusion and low hepatocyte yield, while a too-high flow rate can compromise
hepatocyte viability. For higher flow rates, a cotton tie is used to facilitate the retention
of the cannula in the portal vein under flow.
Prepare rat for surgery
14. Using a 25-G needle fixed on a 1-ml syringe, a dose of Sagatal (1 µl/g) is used to
anaesthetize the rat. The fur at the site of perfusion is wiped with 70% ethanol to
minimize any contamination of the hepatocytes.
15. After the rat is immobilized and the eyes stop blinking, the animal is transferred to
the surgical tray which has been pre-lined with blue roll, and the animal’s limbs are
secured to the tray with tape, ventral side up.
16. Ensure that the animal is insensate before proceeding by pinching firmly on the rear
foot pads and watching for a reflex response. Wait for cessation of reflex responses
before initiating surgical procedure.
In general, this should take between 5 and 10 min.
Perform surgery
17. A V-shape incision is made through both the skin and muscle from the center of the
lower abdomen to the rib cage. The guts are moved to the right to reveal the hepatic
portal vein, and a cotton tie is placed around the vein.
18. The diaphragm is opened and the ribs are cut at either side and pinned back above
each forepaw to reveal the thoracic cavity.Kyffin et al.
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19. The hepatic portal vein is then cannulated with an 18-G cannula, the inner needle is
removed to leave the cannula in the vein, and the cotton tie is then tightened. At this
point, the heart is removed to allow free flow of perfusion buffers.
20. Perfuse the liver with the wash buffer and start the timer for 9 min.
Successful cannulation will be followed by a rapid blanching of the tissue, which will
become a cream/yellow color.
Detailed visual instructions on rat hepatocyte isolation can be found in Shen, Hillebrand,
Wang, & Liu (2012).
Digestion of the liver tissue
21. When the liver has been perfused for 7 min with wash buffer, add the collagenase
A (see step 4; stored on ice) and trypsin inhibitor (see step 4; stored on ice) to the
pre-warmed digestion buffer (see step 1) and mix gently. Following perfusion with
wash buffer, stop pump and transfer tube to perfuse with digestion buffer.
22. Perfuse with digestion buffer until the liver is clearly digested under the capsule
(approximately 2 min).
23. While the liver is digesting, prepare the centrifugation buffer (for the release of the
cells into the petri dish). Add 20 mg DNase I (see step 4; stored on ice) to 200 ml
wash buffer for hepatocyte isolation.
Isolation and purification of hepatocytes
24. At the end of the digestion, stop the perfusion and transfer the digested tissue to a
plastic petri dish containing some of the centrifugation buffer made above in step
23 (wash buffer + DNase I).
25. Anchor the tissue and break the capsule with cross-action forceps. Disturb the tissue
gently with the forceps to release the cells into the centrifugation buffer.
26. Remove the residual tissue and filter the cell suspension through a 125-µm nylon
gauze, which has been pre-wetted with the centrifugation buffer, into the sterile
beaker (see step 8). Repeat until few cells are appearing in the buffer.
27. Split the filtered cell suspension into the two 50-ml pre-cooled conical tubes
(see step 4) and allow cells to settle for approximately 10 min on ice.
28. Remove the supernatant and gently resuspend the cells in the centrifugation buffer.
Spin tubes for 2 min at 50 × g, 4°C.
29. Remove the supernatant and resuspend in complete Williams’ Medium E (25 ml;
see step 2).
30. Centrifuge tubes 2 min at 50 × g, 4°C.
31. Remove the supernatant and resuspend each pellet in complete Williams’ Medium
E (25 ml).
32. Spin tubes 2 min at 50 × g, 4°C.
33. Remove the supernatant and pool cells and resuspend pellet in 40 to 50 ml of
complete Williams’ Medium E.
Cell counting and viability measurements
34. To a 0.5-ml microcentrifuge tube, add 90 µl trypan blue and 10 µl of the cell
suspension. Mix well.
Kyffin et al.
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35. Put 10 µl of the resulting suspension onto a hemacytometer. Count total cells and
blue cells in four quadrants (Q).
36. Calculate the number of viable cells in the preparation:
For each Q, calculate the number of viable cells:
Viable cells in quadrant 1 (Q1) = total cells− blue cells (dead cells)
Then calculate the number of viable cells isolated:
Mean number of viable cells per quadrant
( Q ) = (Q1+ Q2+ Q3+ Q4)
4
Viable cells per ml = Q× 10, 000× dilution factor
where dilution factor = 10
Total number of viable cells in suspension
= viable cells per ml× total volume of cell suspension in ml
37. Viability must be 85% in order for cell culture to proceed successfully
BASIC
PROTOCOL 3
PRIMARY RAT HEPATOCYTE SPHEROID CULTURE
This protocol has been designed to generate homogenous 3D spheroids from freshly
isolated PRHs. It provides instructions as to the spheroid culture conditions required
for freshly isolated PRHs. To obtain the cells for 3D spheroids, rat hepatocytes
are isolated from young male Wistar rats (Basic Protocol 2). Using LOT or ULA
plates, PRH spheroids are generated from a specified initial cell seeding density, re-
sulting in spheroids with a uniform size and reproducible phenotypic characteristics.
This protocol is initiated directly after the isolation procedure as described in Basic
Protocol 2.
Materials
Freshly isolated PRHs (stored on ice)
Complete Williams’ Medium E (see recipe)
Pre-prepared agarose-coated 96-well plates (see Basic Protocol 1; minimum of
2 weeks at 4°C for appropriate plate hydration)
Sterile reservoirs (STARLAB E2310-1010)
200-µl filter tips (Elkay AER-REF-S96)
Multichannel pipettor
Sterile phosphate-buffered saline (PBS), pH 7.2 (Thermo Fisher Scientific
20012019)
Centrifuge with rotor adapter for 96-well plates
1. Agarose-coated 96-well plates are pre-warmed in an incubator at 37°C for 30 min
prior to cell seeding.
2. Agarose-coated 96-well plates are then left to air dry in laminar flow cabinet in order
to remove condensation from plate lids.
Kyffin et al.
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Figure 2 Morphology of spheroids produced using the liquid-overlay technique (LOT). (A) A
phase-contrast image of a properly formed spheroid produced using 4000 PRH at day 3. (B) An
example where a spheroid has failed to form correctly. Scale bar = 100 µm.
IMPORTANT NOTE: This is a vital step in the procedure, as condensation remaining in
the lids considerably affects the ability to form spheroids.
3. Determine how many cells are required for each spheroid and dilute the cell so-
lution to the correct concentration (note that each spheroid is cultured in 100 µl
complete Williams’ Medium E). For example, for 2000 cells/spheroid, we require
2000 cells/well in 100 µl, i.e., a cell density of 20,000 cells/ml. Use the C1V1 =
C2V2 rule to dilute the cells to the appropriate concentration, taking into account
that we require 60 spheroids per plate:
C1 = Cell density calculated above
C2 = Cell density required (e.g., 20,000 cells/ml)
V2 = Volume required (e.g., 6 ml per plate. Always make in excess—we
suggest 7 ml per plate)
V1 = Calculate the volume of cell suspension to add to volume required.
The number of cells required for each spheroid is dependent on the individual experiment.
However, past a certain size, a necrotic core will form. For further details, please refer
to Kyfinn et al. (2019).
4. Add 100 µl of cell suspension to each of the inner 60 wells of the 96-well agarose-
coated plate, using a sterile reservoir, multichannel pipettor, and 200-µl filter tips.
5. Fill the outer 36 wells of the plate with sterile PBS.
6. After all plates have been seeded with cells, the plates are briefly pulse-centrifuged—
90 sec at 100 × g.
This is required to ensure that all cells seeded go to the the bottom and center of the well.
This will bring cells into close contact and increase the likelihood of spheroid formation.
7. Incubate for 72 hr undisturbed at 37°C with 5% CO2 until compact spherical struc-
tures are visible (ensure that the incubator is not opened and closed within the first
72 hr, as this will disturb the formation of the spheroids).
8. Change the medium twice weekly by removing 50 µl old medium and adding 50 µl
new complete medium.
For PRHs isolated on a Monday, medium changes are required on Thursday (day 3)
and the following Monday (day 7). Cell seeding between 2000 and 5000 cells results
in the formation of spheroids of approximately 200 to 500 µm in diameter, which are
visible by eye. See Figure 2 for examples of a properly formed PRH spheroid typified
by a regular and smooth encapsulating membrane around a single spheroid (Fig. 2A).
Figure 2B exemplifies the failed formation of spheroids, where the cells have collected in
the center of the well but have not resulted in the formation of a single 3D spheroid. Kyffin et al.
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BASIC
PROTOCOL 4
IMMUNOFLUORESCENT ANALYSIS OF PRIMARY RAT HEPATOCYTE
SPHEROIDS
In our complex spheroid model, the analysis of cellular morphology and location of
substructures is facilitated via the implementation of immunofluorescent staining. Im-
munofluorescence uses a primary antibody against cell-specific markers and a secondary
antibody linked to a fluorophore, a fluorescent compound that can emit a detectable light
signal upon excitation with specific wavelengths of light. We implemented this protocol
to analyze and visualize the formation of secondary structures such as bile-canaliculi-like
structures that form throughout the PRH spheroid model, and to ensure that in vivo-like
cellular polarization of hepatocytes is achieved.
Materials
Spheroids in 96-well culture plate (Basic Protocol 3)
Phosphate-buffered saline (PBS), pH 7.2 (Thermo Fisher Scientific 20012019)
4% paraformaldehyde pH 7.2 (Merck-Sigma P6148)
Permeabilization buffer (see recipe)
Block buffer (see recipe)
Anti-P-gp primary antibody [EPR10364-57] (Abcam ab170904)
Alexa Fluor 568 donkey anti-mouse secondary antibody (Abcam ab175472)
Immunofluorescence wash buffer I and II (see recipe)
Hoechst 33342 stain (Abcam ab228551)
Phalloidin 680 stain (Thermo Fisher Scientific A22286)
Prolong Gold Antifade Mountant (Thermo Fisher Scientific P36934)
Clear nail polish
96-well microplate (Thermo Fisher Scientific 10212811)
20-µl filter tips (Elkay AER-OREF-S96)
200-µl filter tips (Elkay AER-REF-S96)
1000-µl filter tips (Elkay AER-STE1-A18)
P20 Gilson repeat pipettor
P200 Gilson repeat pipettor
P1000 Gilson repeat pipettor
Aluminum foil
Microscope slide, Superfrost, 76 mm × 26 mm (Thermo Fisher Scientific
10149870)
Cover slips 22 mm × 50 mm (Fisher Scientific 12373128)
Kimwipes
Fluorescence microscope
Day 1: Fixation and permeabilization of spheroids
1. In the class II biological safety cabinet, spheroids to be stained for immunofluores-
cence are transferred from the cell culture plate into a fresh 96-well microplate (not
agarose-coated) using a P200 repeat pipettor with a 200-µl tip.
These PRH spheroids produce high levels of extracellular matrix structures throughout
the microtissue, and therefore transferring spheroids from one plate to another does not
disrupt the structure.
2. Remove the new plate containing the spheroids from the hood for staining.
These are going to be fixed, and therefore no longer require aseptic handling.
3. Remove medium using a 200-µl repeat pipettor and 200-µl filter tips. Wash the
spheroids three times, each time by adding 100 µl PBS and then removing the PBS.
100-µl volume is used per well for all subsequent steps including antibody incubations.Kyffin et al.
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4. Fix spheroids with 4% paraformaldehyde for 1 hr at 4°C.
5. Remove the paraformaldehyde using a 200-µl repeat pipettor and a 200-µl filter
tip and discard in a chemical waste bin. Wash the spheroids by adding 100 µl of
immunofluorescence wash buffer I and then removing it with a 200-µl repeat pipettor
and a 200-µl filter tip. Repeat this three times.
After this step, spheroids can be resuspended in PBS, pH 7.2, and left for 2 weeks at
4°C in a sealed plate.
Cells are then permeabilized to allow the penetration of antibodies inside the cell.
6. 100 µl of permeabilization buffer is added to each well and the spheroids kept at
4°C overnight.
Day 2: Blocking and incubation with primary antibody
Nonspecific binding is blocked by the addition of bovine serum albumin (BSA). In this
study, we monitor hepatocellular polarization and the presence of bile canalicular by the
fluorescent localization of P-gp, which is present at the bile canalicular membrane.
7. Remove permeabilization buffer and add 100 µl block buffer for 2 hr at room
temperature.
8. Dilute Anti-P-gp primary antibody 1:50 in block buffer.
9. Remove the block buffer and add 100 µl of the primary antibody dilution from step
8. Cover the plate with foil and incubate spheroids overnight at 4°C.
As a negative control, incubate additional spheroids without the primary antibody.
Day 3: Secondary antibody and stains
In order to detect immunofluorescence, secondary antibodies are conjugated with fluo-
rescent tags that are excited at specific wavelengths.
10. Spheroids are washed with immunofluorescence wash buffer II three times, each
time for 1 hr at room temperature.
11. Dilute Alexa Fluor 488 donkey anti–mouse secondary antibody (1:1000), Hoechst
33342 stain (1:5000), and phalloidin 680 (1:250) together in block buffer.
12. Remove wash buffer and add 100 µl/well of the secondary antibody/stain mixture
prepared in step 11. Note that secondary antibodies are light sensitive and, at this
stage, exposure to light should be minimized. Cover the plate with foil and incubate
the spheroids overnight at 4°C (without rocking).
Day 4: Mount cells for visualization
In order to maintain cells for immunofluorescent visualization, the spheroids are mounted
and maintained in Prolong Gold fixative. Throughout this stage of the protocol, exposure
to light should be minimized.
13. Spheroids are washed with 100 µl wash buffer I for 1 hr at room temperature in the
dark.
14. Transfer spheroid in a small amount of buffer to a Superfrost microscope slide using
a P1000 repeat pipettor and 1000-µl filter tip (this ensures that spheroids remain
undamaged). Remove excess liquid from the slide using a pipette and Kimwipe.
15. Add approximately 10 µl of Prolong Gold Antifade Mountant using a P20 repeat
pipettor and 20-µl filter tip to cover the spheroid, and gently place coverslip on top.
Kyffin et al.
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Figure 3 P-gp staining of bile canalicular formation throughout spheroids. 3000-cell spheroids
were cultured on liquid-overlay plates for 3 days, fixed, and stained with P-gp (green). A maximum
intensity projection image was taken at 40× magnification. Scale bar = 20 µm.
Be careful to avoid creating bubbles in the mountant, as this will interfere with imaging
analysis. Try to avoid applying too much pressure with the coverslip, as this will distort
the spheroid.
16. Use nail polish to seal the coverslip on the slide and let it dry in the dark for
approximately 30 min.
17. Image analysis can be carried out as soon as slides have dried, or slides can be stored
in a slide box at 4°C.
Cells will maintain fluorescent signals over a few months (see Fig. 3 for an example
of P-gp-stained PRH spheroid and the type of results that should be expected from the
immunofluorescent analysis described in this protocol).
REAGENTS AND SOLUTIONS
Centrifugation buffer (200 ml)
200 ml wash buffer (see recipe)
20 mg DNase I ((Merck-Sigma D5025; add as described in Basic Protocol 1)
Prepare fresh for each use
Complete William’s medium E
William’s medium E basal medium (Merck-Sigma W1878) containing:
10% heat-inactivated FBS (Thermo Fisher Scientific A3840401)
1% penicillin-streptomycin (100×; Thermo Fisher Scientific 15140122) giving a
final concentration of 100 units/ml penicillin and 0.1 mg/ml streptomycin
2 mM L-glutamine (Thermo Fisher Scientific 25030032)
10 µg/ml insulin, 5.5 µg/ml transferrin, 6.7 ng/ml selenium (add as
insulin/transferrin/selenium solution; Thermo Fisher Scientific 41400045)
100 nM dexamethasone (Merck-Sigma D4902)
Store up to 1 month at 4°C
Digestion buffer (100 ml)
99.5 ml of wash buffer (see recipe)
0.5 ml of 1.325 M CaCl2 solution consisting of 73.5 mg calcium chloride dihydrate
(CaCl2·2H2O; Merck-Sigma C7902) dissolved in 0.5 ml deionized water
Prepare fresh for each use
Kyffin et al.
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Immunofluorescence block buffer
Immunofluorescence permeabilization buffer (see recipe) plus 3% BSA. Store up to
1 week at 4°C.
Immunofluorescence permeabilization buffer
Phosphate-buffered saline (PBS; Thermo Fisher Scientific 20012019) containing:
0.5% (v/v) Tween 20
0.2% (v/v) Triton X-100
Store up to 1 week at 4°C
Immunofluorescence wash buffer I
1× phosphate-buffered saline (PBS; Thermo Fisher Scientific 20012019).
Immunofluorescence wash buffer II
Phosphate-buffered saline (PBS; Thermo Fisher Scientific 20012019) containing:
0.1% Tween
0.2% Triton-X100
Store up to 1 week at 4°C
Wash buffer for hepatocyte isolation (1 L)
100 ml 10× Hanks balanced salt solution (HBSS; Thermo Fisher Scientific
14185045)
1.38 g HEPES (Merck-Sigma H4034)
900 mM sodium bicarbonate (NaHCO3) (Merck-Sigma S5761; 378.05 mg
NaHCO3 in 5 ml of deionized water)
895 ml deionized water
Prepare fresh for each use
COMMENTARY
Background Information
Methods for culturing rat hepatocytes in 2D
have been established for a number of years,
but to our knowledge, no definitive studies
have described conditions showing the imple-
mentation of LOT and agarose-coated ULA
plates for the formation of primary rat liver
spheroids. In more recent years, 3D cultures
of hepatocytes and hepatic-derived cell have
become increasingly utilized for hepatotoxi-
city investigations due to the rapid develop-
ment of more amenable, cost-effective, and
uncomplicated culture methodologies. One of
the major limitations to the mainstream adop-
tion of commercially available 3D liver models
is their cost; as such, the need for more cost-
effective approaches has been a considerable
driver in development of bioengineered liver
culture models. Using the protocols in this
article, isolated PRHs can be cultured for at
least 30 days in agarose-coated plates, which
provide a ULA surface for spheroid forma-
tion. These plates cost a fraction of the price
of their commercially available counterparts.
Thus, this model provides an adequate experi-
mental platform to carry out early-stage hepa-
totoxicity studies, related to human risk poten-
tial, for novel xenobiotic development across
industry sectors. More specifically, due to the
formation of functional bile-canalicular struc-
tures, the described PRH spheroids may pro-
vide further insight into the mechanisms of
hepatobiliary transport–associated manifesta-
tions of toxicity.
One of the key advantages that 3D liver
cell cultures have over their 2D counterparts is
that the complexity of the native microenviron-
ment is conserved over extended periods. The
recent progress in 3D in vitro liver spheroid
models may lead to an improved ability to
predict hepatotoxicity of novel compounds,
owing to the establishment of a more phys-
iologically relevant environment as seen in
the in vivo liver (Andersson, 2017). The lit-
erature has reported that the re-establishment
of cellular polarization is a vital process that
facilitates the maintenance of gene expres-
sion and hepatocyte-specific function (Dunn,
Tompkins, & Yarmush, 1991). 2D liver cul-
tures have a limited capability for estab-
lishing polarized cellular conformations that
display the multiple apical and basolateral Kyffin et al.
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membranes as seen in vivo. Therefore, it is
crucial that novel and alternative in vitro liver
models have the ability to restore this hallmark
of liver physiology.
Researchers have reported numerous 3D
liver models that enable the establishment of
cellular polarization, including hydrogel- and
scaffold-based technologies, as well as liver
spheroids (Bell et al., 2016; Fang & Eglen,
2017; Gaskell et al., 2016; Knight, Murray,
Carnachan, & Przyborski, 2011; Kyffin et al.,
2019; Lee et al., 2015; Napolitano et al., 2007;
van Zijl & Mikulits, 2010). The LOT method
to culture PRH spheroids has a number of
advantages over other methods for spheroid
generation. Primarily, the size of the resulting
spheroids is simply manipulated by changing
the initial cell seeding density in the 100 µl
of medium within the culture well. Secondly,
this method of spheroid generation does not
require any specialized and expensive equip-
ment for experimental setup, and a single iso-
lated liver from one animal provides a vast
amount of cells to cover multiple experimental
repeats. The LOT provides a culture platform
where PRHs rapidly aggregate into a single
central spheroid at the base of the agarose-
coated culture well, 72 hr post seeding. Com-
paction of the spheroid occurs over the dura-
tion of the culture time due to upregulation
and expression of ECM components, resulting
in a spheroid composed of polarized cuboidal
hepatocytes embedded in matrix (see Fig. 4
for phase-contrast microscopy images of com-
pacting 2000-cell spheroids over 31 days of
culture).
Critical Parameters and
Troubleshooting
The viability of PRHs after the isolation
procedure is vitally important for the ap-
propriate culture of viable spheroids and for
subsequent spheroid analysis. One of the
critical considerations for the culture of PRH
spheroids is ensuring that culture plates have
been pre-warmed and that once culture plates
have been transferred into the culture hood
for cell seeding, all of the condensation on
the plates and lids has completely evaporated
(pre-warming and condensation evaporation
within the plates takes approximately 45 to
60 min). The culturing of PRH spheroids
utilizing the LOT is predominantly influenced
by factors such as uninterrupted culture post-
seeding, adequate airflow in the incubator, and
ensuring that the reagents are used at the same
temperature, e.g., the complete Williams’
Medium E. Additionally, the maintenance of
these critical parameters will ensure virtually
complete aggregation and compaction of the
PRHs into a single spheroid after 72 hr of cul-
ture. For proper formation of PRH spheroids
by the LOT, isolated rat hepatocytes should be
of high viability (>85%) and suspended at cell
concentrations of 2000 cell per well. When
seeding cells into the culture plates, careful
mixing of the cell suspension in the sterile
reservoirs before pipetting ensures a homoge-
nous suspension and that equal and uniform-
sized spheroids will be produced. Further-
more, care must be taken when carrying out
medium changes to ensure that spheroids are
not damaged or lost. For immunofluorescence
analysis, extreme care must be taken when
mounting processed spheroids so they are
not damaged or flattened and distorted. There
have been numerous papers discussing poten-
tial limitations of spheroids, and, in particular,
the incidence of necrosis due to hypoxia has
been a key issue of these broader discussions.
Although we have not included additional
experimental and collaborating mathematical
analysis in this manuscript related to our
investigations of oxygen utilization, we can re-
fer readers to Kyffin (2018) where we describe
optimized operating conditions for this exper-
imental spheroid model to recapitulate oxygen
gradients as seen in the liver sinusoid in vivo.
Furthermore, Chapters 3 and 4 in Kyffin
(2018) describe model-specific experimental
and in silico modeling for oxygen utilization
as well as xenobiotic distribution and cellular
transport routes/bioavailability. In summary,
we show that our specific PRH spheroid model
remains devoid of necrosis for the entirety of
the standard 31-day culture period, and that
by fine-tuning external oxygen concentrations
(i.e., oxygen in the incubators), in vivo
sinusoidal oxygen tensions can be replicated.
Understanding Results
The generation of PRH spheroids using the
LOT cultured in agarose plates is expected
to produce spheroids approximately 200 to
500 µm in diameter in each well when sus-
pended in 100 µl of culture medium. This
will depend on the initial cell seeding den-
sity chosen (our previous work has analyzed
spheroids at 2000- 5000-cell initial seeding
densities; Kyffin et al., 2019). Approximately
90% of the initial amount of cells seeded
are incorporated in the spheroid culture after
72 hr of culture in agarose plates. Spheroid
cultures will reduce in size/diameter over the
duration of the culture period due to the upreg-
ulation of ECM and cytoskeletal components,Kyffin et al.
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Figure 4 Compaction of 2000-cell spheroids over 31 days of culture. Phase-contrast images
of spheroids were taken at days 3, 7, 11, 18, 21, 28, and 31 of the culture period. Scale bar =
100 µm.
resulting in spheroidal compaction. This has
been observed and well documented previ-
ously (Bell et al., 2016; Lin, Chou, Chien,
& Chang, 2006). Immunofluorescent analy-
sis with P-gp should result in the staining of
fine, bile-canaliculi structures throughout the
PRH spheroids. These structures are extensive
and are expected to be approximately 0.5 to
2.5 µm.
Time Considerations
The amount of time required for rat hepa-
tocyte isolation was discussed in Basic Proto-
col 2, with this procedure generally taking up
to 1 hr. Using this modified two-step collage-
nase perfusion method, 3 × 108 hepatocytes
per rat liver can be obtained, with an aver-
age viability 85%. Based on the cell seeding
density described in Basic Protocol 3, usually
one experimental setup requires seven plates
of spheroids per seeding density (2000, 3000,
4000, and 5000 cells per well in 60 wells).
Therefore, one experimental setup requires ap-
proximately 5.88 × 106 hepatocytes for all
of our chosen cell-seeding densities. Cells are
then cultured using the LOT, and the culture
medium changed twice weekly. The time re-
quired to change the medium depends on the
number of plates. Generally, it takes approx-
imately 1.5 hr to change the medium in 28
plates using a multichannel pipettor. This may
take longer, as it is vital that spheroids not be
removed/lost from the well during the chang-
ing of culture medium. The time required to
complete the immunofluorescent staining pro-
tocol described in Basic Protocol 4 is approxi-
mately 4 days due to the overnight incubations
required for primary and secondary antibodies.
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